Sharemaestro Newsreel

Bank of America (OM) reports 3.5% beneficial stake in Outset Medical shares

Bank of America Corporation has reported a beneficial ownership of 3.5% in Outset Medical, Inc., holding 666,596 shares of common stock. This stake, representing a shared voting and dispositive power, is held through several of its wholly-owned subsidiaries. The filing indicates that Bank of …

AQR Capital discloses 6.44% Inspire Medical Systems (INSP) ownership on Schedule 13G

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 6.44% in Inspire Medical Systems, Inc. (INSP) through a Schedule 13G filing. The AQR entities collectively own 1,856,800 shares, with shared voting power over 1,783,224 shares …

Orthofix (OFIX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief IR and Communications Officer - Julie Dewey President and Chief Executive Officer - Massimo Calafiore Chief Financial Officer - Julie Andrews Full Conference Call Transcript Operator: Thank …

GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know

GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates. This upgrade suggests an improvement in the company's underlying business and could lead to a favorable impact on its stock price. The Zacks Rank …

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

Ceribell Wins FDA Nod for AI Tools on Its Neurology Portal

Ceribell has received FDA 510(k) clearances for two AI enhancements integrated into its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These tools aim to improve the diagnosis of epilepsy and streamline the interpretation of EEGs by automatically highlighting abnormal brain wave patterns …

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …

CVRx chief revenue officer exits amid slowing sales and execution concerns

CVRx Inc. has announced the departure of its chief revenue officer following a reduction in its full-year revenue guidance. The company attributes the lowered outlook to employee turnover and productivity issues, which have impacted sales of its primary product, Barostim, a device for heart …

PBH or SYK: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own …

Insulet (PODD) Could Be 39% Undervalued After Strong Earnings And Higher 2026 Outlook

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

NeuroPace (NPCE) reported strong second-quarter 2026 results, with earnings and revenues surpassing Zacks Consensus Estimates, driven by significant growth in its RNS System. The company also raised its full-year 2026 revenue guidance and improved its adjusted EBITDA loss outlook. NeuroPace highlighted advancements in AI-based …

Medtronic veteran departs for CEO role at heart valve startup

Bill Shields, a long-time Medtronic executive specializing in transcatheter mitral and tricuspid therapies, has been appointed CEO of Versa Vascular. Versa Vascular is a startup developing a minimally invasive transcatheter device called AdapTR to treat tricuspid valve regurgitation. Shields' appointment comes as Versa Vascular …

BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $18

BofA Securities has maintained its Hold rating on Beta Bionics (BBNX.US) and increased its target price for the company's stock to $18. This adjustment reflects BofA's updated outlook for Beta Bionics.

LivaNova (LIVN) Q2 2026 Earnings Call Transcript

LivaNova reported record Q2 2026 revenue of $390.6 million and adjusted diluted EPS of $1.26, exceeding prior-year figures, driven by strong demand in Cardiopulmonary and Epilepsy segments. The company raised its full-year 2026 revenue guidance to 8%-9% growth and adjusted diluted EPS guidance to …

Earnings call transcript: IceCure Medical misses Q2 2026 estimates as shares fall

IceCure Medical reported a 45% year-over-year revenue increase to $1.8 million for the first half of 2026, driven by higher ProSense system sales and disposable probe utilization. The company's U.S. commercial install base grew by 70% to over 30 sites following FDA clearance for …

Mobia Medical (NASDAQ:MOBI) Price Target Raised to $17.00

JPMorgan Chase & Co. has increased its price target for Mobia Medical (NASDAQ:MOBI) to $17.00 from $15.00, maintaining an "overweight" rating and suggesting a 35.24% upside. Despite the company's revenue more than doubling year-over-year to $13.51 million, it reported a larger-than-expected loss of $1.10 …

What Abbott Laboratories (ABT)'s AI-Powered Google Health Partnership Means For Shareholders

Abbott Laboratories has partnered with Google Health to integrate glucose insights from its Lingo biowearable into the Google Health app, using AI for personalized metabolic health coaching and unified wellness data. This collaboration includes a large-scale metabolic health study, potentially supporting Abbott's diabetes franchise …

Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake

Capital International Investors has reported a 6.4% ownership stake in Zimmer Biomet Holdings, Inc. (ZBH), totaling 12,438,366 shares. This passive investment grants them sole voting power over 12,279,364 shares and sole dispositive power over all 12,438,366 shares, as detailed in a Schedule 13G SEC …

908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference

908 Devices Inc. announced that its CEO and CFO will present at the 17th Annual Midwest IDEAS Conference on August 26, 2026. The company, which specializes in handheld chemical analysis tools, will host investor meetings and webcast its presentation. This event provides an opportunity …

ITOC, PTHL UPCOMING DEADLINE: Levi & Korsinsky Alerts iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) Stockholders of Securities Class Action - Contact the Firm

Levi & Korsinsky, LLP has filed a securities class action lawsuit against iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) (NASDAQ: ITOC, PTHL) on behalf of shareholders who purchased securities between September 5, 2024, and July 29, 2025. The lawsuit alleges that iTonic warned generically …

AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky, LLP has issued a securities investigation notice for AdaptHealth Corp. (AHCO) after the company reported second-quarter 2026 revenue and earnings significantly below analyst expectations. Shares of AdaptHealth fell as much as 26% following the announcement of a $0.99 GAAP loss per …

AdaptHealth misses Q2 revenue and earnings estimates, shares drop 26%.

AdaptHealth Corp. (AHCO) reported a significant miss on Q2 2026 revenue and earnings estimates, with revenue at $740.3 million against an anticipated $847 million, and a GAAP loss of $0.99 per share compared to an expected loss of $0.15. This poor performance led to …

Smith & Nephew (SNN): executive share awards vest, partial sale to cover tax

Smith & Nephew plc reported that performance share awards granted in 2023 to Rohit Kashyap, President of Advanced Wound Management and Global Commercial Operations, vested on August 12, 2026. Of the 23,202 ordinary shares that vested, 9,163 were sold to cover tax liabilities, with …

REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & Nephew Plc has announced transactions made by Persons Discharging Managerial Responsibilities (PDMRs) and closely associated persons following the vesting of awards under its Global Share Plan 2020 and Restricted Share Plan 2024. The announcement details the vesting of 2023 Performance Share Awards, …

PLNT Investor Alert: Planet Fitness, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Planet Fitness, Inc. (NYSE: PLNT) on behalf of investors who purchased securities between November 6, 2025, and May 6, 2026. The lawsuit alleges that Planet Fitness made misleading statements regarding its marketing strategy …

UFP Technologies Director Joseph John Hassett Files Corrected Beneficial Ownership Amendment

UFP Technologies Director Joseph John Hassett has filed an amended statement of beneficial ownership to correct an administrative error in a previous filing. The amendment updates his beneficial ownership from 2,425 to 2,602 shares of Common Stock. This correction relates to a transaction on …

UFP Technologies (UFPT) director amends Form 4 to correct 2,602-share holding

UFP Technologies director Joseph John Hassett has filed an amended Form 4 to correct an administrative error in his previously reported share holdings. The amendment clarifies that his correct beneficial ownership of Common Stock, $.01 Par Value, following a reported transaction was 2,602 shares, …

Lumexa Imaging earnings on deck: Profitability in focus

Lumexa Imaging Holdings Corp. is set to report Q2 earnings, with investors focused on the company's ability to maintain profitability and execute its growth strategy. Analysts expect an EPS of $0.20, an 11% sequential improvement, and all eight analysts rate the stock a Strong …

PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has issued a shareholder alert regarding a securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that former EVP and COO Eric Benjamin made false statements about Omnipod product safety while selling $3.7 million in company stock. …

ENvue Medical secures $50M equity financing facility By Investing.com

ENvue Medical, Inc. has announced a securities purchase agreement with an institutional investor for an equity financing facility of up to $50 million, subject to stockholder approval. The medical technology company plans to use the capital to advance its technology platform, accelerate the adoption …

Every 2 Seconds, Someone in the U.S. Needs Blood as Abbott Drive Returns

Abbott (NYSE: ABT) and the Big Ten Conference have relaunched their "We Give Blood" nationwide competition to address a critical blood supply crisis in the U.S. All 18 Big Ten universities will compete to generate the most blood donations, with Abbott awarding $1 million …

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

This article summarizes recent analyst ratings for three healthcare companies: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX), and Agios Pharma (AGIO). Bank of America Securities maintained a Hold rating on GEHC, while Truist Financial analysts maintained Buy ratings on both Vertex Pharmaceuticals and …

Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)

Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher

Quanterix (QTRX) recently released its Q2 2026 earnings report, showing higher revenue but a wider net loss and a lowered full-year revenue outlook, alongside the appointment of a new Chief Commercial Officer. Despite these mixed results, the stock saw a brief rebound, suggesting investors …

IceCure Medical (Nasdaq: ICCM) lifts H1 revenue 45% but burns cash

IceCure Medical Ltd. (ICCM) reported a 45% increase in H1 2026 revenue to $1.818 million, driven by higher system and disposable probe sales. Despite this growth, the company experienced a deepened net loss of $8.775 million and negative operating cash flow, leading management to …